BEAM-103
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BEAM-103, covering 2025-12-26 to 2025-12-26. Get the full timeline:
Most recent: Clinical Trial Update: This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of BEAM-103 in Healthy Subjects [Phase 1]